Jan 20 (Reuters) - Novavax ‌said on Tuesday it signed a licensing ‌agreement allowing Pfizer access to its technology that boosts immune responses to vaccines for use in up to two infectious diseases, ...
Silvia Taylor of Novavax details how the company leverages its expertise in vaccine development to build partnerships across ...
Vaccine maker Novavax inked a three-year supply deal to include its adjuvant in vaccine research backed by an arm of the Bill & Melinda Gates Foundation. As part of the accord, Novavax will provide ...
Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 11.3% in the afternoon session after documents revealed ...
On May 10, Novavax announced a co-exclusive licensing agreement with healthcare giant Sanofi. The companies are going to work together on commercializing Novavax's adjuvanted COVID-19 vaccine ...
First, a quick summary of Novavax's story so far. The vaccine maker's shares soared early in the COVID-19 vaccine race, skyrocketing more than 2,000% in 2020 as investors bet on its vaccine candidate.
Robert Walker, MD, brings more than 30 years in drug and vaccine development and, most recently, served as Novavax's Chief Medical Officer Dr. Walker will continue advancing Novavax's R&D efforts with ...
Good morning, and welcome to Novavax' First Quarter 2024 Financial Results and Operational Highlights Conference Call. All lines will be in a listen-only mode. [Operator Instructions]. Please note ...
After opening the year projecting COVID vaccine sales of between $800 million and $1 billion, Novavax has slashed its estimate to a range of $275 million to $375 billion. (Photo by Patrick van Katwijk ...
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Novavax is a biotechnology company specializing in the ...
Novavax is a biotechnology company specializing in the development of recombinant protein-based vaccines, including its COVID-19 shot and the adjuvant Matrix-M, which enhances immune responses. Its ...